Frazier Financial Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 490 shares of AMRX stock, worth $4,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
490
Previous 1,644
70.19%
Holding current value
$4,076
Previous $10.4 Million
60.95%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$181 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$122 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.2 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.26B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...